XTalks

FEBRUARY 16, 2022

The drug was developed by Orchard Therapeutics and the NHS was able to negotiate a greater discount on it with the company so that it can offer it to patients in England. The team also talked about a digital risk report that revealed the existence of significant cybersecurity vulnerabilities among the world’s top pharma companies.

Life Science 52

Life Science Gene Therapy Drugs Pharma Companies 52

pharmaphorum

DECEMBER 16, 2022

Ben Hargreaves discovers why some have referred to the distribution of COVID-19 vaccines and treatments as a form of apartheid. Further, with a pandemic treaty in development, there are reasons to believe that many countries and the WHO want to see a more equitable distribution of medical products for future pandemics.

Vaccination 84

Vaccination Vaccine Production Licensing 84

Drug Discovery World

OCTOBER 6, 2022

With key players including AstraZeneca, Bayer, Novartis and Pfizer pushing the boundaries of drug development, the reason behind this growth is evident. According to McKinsey & Company: “Europe’s complex biotech landscape comprises hundreds of companies, dozens of countries, and multiple paths to innovation and financing… .

Development 52

Development Drugs Life Science Marketing 52

XTalks

OCTOBER 4, 2023

In my current role, I have country-level responsibility for AstraZeneca’s entire portfolio, including cardiovascular, respiratory, vaccines and oncology. How do you make strategic decisions around products that are in the early stage of development and are still years from regulatory approval and launch?

Marketing 105

Marketing Development Drugs Gene Therapy 105

Drug Discovery World

MAY 6, 2024

Thanks to a prestigious academic legacy, Europe has long been a dominant region for life sciences. In this article, DDW’s Diana Spencer highlights several prominent hotspots that are taking the lead on advancing European drug discovery and development. This article takes a closer look at several key clusters in the region.

Drugs 59

Drugs Life Science Gene Editing Gene 59

pharmaphorum

FEBRUARY 25, 2022

The past two years have shone a spotlight on the UK life sciences industry. Pharma companies are now household names, having been thrust into the public’s consciousness after dominating the headlines through the pandemic. An industry that will forever play a greater role in our everyday lives. About the author.

Life Science 95

Life Science Vaccination Vaccine Pharmacy 95

Delveinsight

JULY 29, 2020

Today the whole world is in a search for an effective vaccine candidate against SARS-CoV-2. The vaccine appears to be the only solution to prevent coronavirus. Several pharma and biotech companies are developing and manufacturing safe and effective vaccines to fight coronavirus.

Vaccination 62

Vaccination Vaccine Clinical Trials Clinical Trials 62

XTalks

MAY 23, 2024

Forbes’ America’s Best Large Employers 2024 list highlights companies that excel in creating exceptional workplace conditions, promoting innovation and supporting their employees’ development and well-being. Established in 1887, the company now operates globally, boasting a workforce of over 30,000 employees.

Life Science 52

Life Science Medicine Manufacturing Engineer 52

pharmaphorum

APRIL 8, 2021

COVID-19 has been a trial-by-fire showing just how quickly drugs and vaccines can be developed under the right circumstances – but there is much to do to ensure this progress is not lost, said speakers at WIRED Health 2021, including the CEOs of BioNTech and BenevolentAI. . BioNTech seeks “new kind of pharma company”.

Development 81

Development Drugs Vaccination Vaccine 81

pharmaphorum

JANUARY 6, 2022

The latest pharma company to make a move for an mRNA specialist is Germany’s Merck KGaA, which has offered a $780 million cash buyout to US biotech Exelead. Outsourcing services are on of the pillars of Merck’s business, delivered via its process solutions unit, part of the group’s life sciences division.

Vaccination 96

Vaccination Vaccine Manufacturing Life Science 96

pharmaphorum

JULY 7, 2022

Eradicating cancer is an ambitious goal for oncologists and life science companies around the world. As this issue’s contributors discuss, by working together pharma companies and healthcare providers can significantly enhance oncology treatment for patients. Realising the promise of cancer vaccines.

Vaccination 52

Vaccination Vaccine Life Science Trials 52

XTalks

AUGUST 27, 2020

With vaccine trials for COVID-19 ramping up and entering late stages, Johnson & Johnson has announced plans for what will be the largest Phase III trial so far for a vaccine against the novel coronavirus. This is double the enrollment that vaccine makers Moderna and Pfizer have planned for their Phase III trials.

Vaccination 52

Vaccination Vaccine Trials Clinical Trials 52

Drug Discovery World

APRIL 27, 2023

The report notes that the focus on science and pharma throughout the Covid-19 pandemic has resulted in the emergence of new locations as life science hubs and name checks Boston, Massachusetts and San Francisco, California as examples of centres with heightened investment appeal in the life sciences 1.

Life Science 52

Life Science Drugs Research Gene Splicing 52

XTalks

MARCH 22, 2023

In October 2022, Xtalks celebrated two decades of bringing diverse stakeholders in the life science industry together through first holding physical events, then soon after, hosting exclusively online events. Pfizer is also the co-developer of what is arguably the most successful COVID-19 vaccine rollout.

Life Science 97

Life Science Drugs FDA Approval Vaccination 97

Drug Discovery World

MAY 22, 2023

Cell therapy, RNA technology, antibody drug conjugates and AI/machine learning are among the key areas of investment for pharma, according to a new report. Clarivate’s ‘Biopharma Dealmaking in 2023’ report examines how pharma companies are replenishing their pipelines as many face a steep patent cliff.

RNA 52

RNA Pharma Companies Antibody Life Science 52

XTalks

DECEMBER 13, 2023

In 2023, biotechnology and pharmaceutical companies leverage cutting-edge technology and significant investments in research and development (R&D) to continue pushing the boundaries of innovation in the healthcare sector, transcending the challenges posed by the pandemic. vaccine, mRNA-1273.815.

Genetics 111

Genetics Vaccination Vaccine DNA 111

pharmaphorum

APRIL 5, 2022

That culture clash makes it hard to innovate the world of pharma at scale and with any rapidity. And investment in pharma followed suit: pharma companies were looked at as stable assets — reliable but unlikely to balloon in value like a tech company might. Start-ups move fast and break things.

Pharma R&D 52

Pharma R&D Life Science Pharma Companies Clinical Trials 52

pharmaphorum

DECEMBER 16, 2020

We’ve got so many great life science assets in the UK, but there are still some gaps – manufacturing capacity being one of them.”. “We We had companies collaborating to develop laboratories. We had companies sourcing consumables for testing machines. The road to a vaccine. A collaborative future.

Vaccination 121

Vaccination Vaccine Life Science In-Vitro 121

pharmaphorum

SEPTEMBER 18, 2020

But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.

Pharma Companies 115

Pharma Companies Sales Vaccination Vaccine 115

pharmaphorum

FEBRUARY 11, 2021

Pharma companies face many challenges when involving patients in the design of clinical trials – but doing so can have huge benefits further down the line, improving the sustainability and quality of research. He said that this can be used to shape trials to make them easier for patients, with potential benefits in terms of adherence.

Clinical Trials 90

Clinical Trials Clinical Trials Trials Clinical Research 90

pharmaphorum

SEPTEMBER 15, 2020

For pharma companies, COVID-19 has proved that they can be agile and responsive to rapidly evolving market conditions, as evidenced by the way they have adjusted to a new global paradigm while successfully continuing operations. Preparing for an agile pharma future. Jeremy Richter, Tag. Build on the rapid responses to COVID-19.

Branding 112

Branding Marketing Pharma Companies Life Science 112

pharmaphorum

DECEMBER 15, 2022

In recent years, social media has evolved into an essential part of pharma operations, for better or worse. Within the life sciences space, traditional ways of leveraging social media include marketing and spreading awareness of a disease or treatment. Sharing information and developing partnerships.

Clinical Trials 90

Clinical Trials Clinical Trials Life Science Marketing 90

XTalks

OCTOBER 22, 2020

Pharmaceutical development of novel drugs is a complex and tedious process. To achieve transparency and actionability of data, pharmaceutical companies are evolving their manufacturing processes by digitalizing the data from all of their equipment. Nevertheless, they have succeeded to continue the process development to the next stage.

Manufacturing 98

Manufacturing Development Production Gene Therapy 98

pharmaphorum

NOVEMBER 23, 2022

A director in life sciences consulting for EY, she works within the commercial space for such companies, as well as their clients. “My We looked at the areas of rare diseases, cell and gene therapy, vaccines – loads of different perspectives. Innovative offerings around market access. Smart reviewing: utilising AI and ML.

Life Science 98

Life Science Marketing Medicine Production 98

XTalks

AUGUST 18, 2021

While infectious disease experts and drug companies have rightfully spent the last 18 months developing therapeutics and vaccines targeting SARS-CoV-2 and COVID-19, another global threat to public health — antimicrobial resistance (AMR) — has, and will continue to, persist until similar direct action is taken.

Development 105

Development Bacteria Drugs Vaccination 105

XTalks

JANUARY 15, 2024

Collaboration Across Sectors Increasing For the past couple of years, industry reports have been highlighting a trend towards ‘ecosystem’ collaborations, involving pharma companies, biotech startups, tech giants, healthcare providers and patient advocacy groups. billion in 2022, and the trend doesn’t appear to be stalling.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Clinical Research 105

The Pharma Data

SEPTEMBER 11, 2020

In an effort to slow the spread of the disease and prevent a second wave, pharma companies around the world are continuously looking to advance new methods of treatment. This week’s round up dives into developments from companies based in Australia and the US. acting, water-soluble version of remdesivir.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drug Delivery 52

pharmaphorum

APRIL 7, 2021

Genmab’s success has been founded on Darzalex (daratumumab), the blockbuster multiple myeloma drug that it developed in partnership with Johnson & Johnson’s Janssen unit. With other drugs in the pipeline too, van de Winkel said the company aims to continue to break new ground with next-generation antibody-based therapies.

Antibody 69

Antibody Life Science Development Regulation 69

XTalks

OCTOBER 15, 2021

The cell line, called HeLa, laid the foundation for many groundbreaking discoveries, including vaccines for the human papilloma virus (HPV) and polio; drugs for HIV and cancers; gene mapping; IVF treatment; and more recently, for crucial COVID-19 research. Fittingly, it was also used to develop the vaccine against cervical cancer.

Vaccination 105

Vaccination Vaccine Gene Mapping Doctors 105

pharmaphorum

DECEMBER 15, 2022

Co-chaired by Lord James O’Shaughnessy and Professor Mike Bewick, former deputy national medical director of NHS England (present online), the NHS Innovation and Life Sciences Commission Report launch took place at One Great George Street, Westminster, on 12th December 2022. The UK as a powerhouse of research.

Life Science 89

Life Science Medicine Clinical Trials Clinical Trials 89

Drug Discovery World

NOVEMBER 16, 2022

DDW Editor Reece Armstrong learns about Molecular Devices’ Organoid Innovation Centre (OIC) and how the company is aiming to advance research into 3D biology and organoids. . One of the goals was to include systems that would help companies overcome common barriers associated with automated organoid culturing and screening. .

Drugs 97

Drugs In-Vivo In-Vitro Scientist 97

pharmaphorum

MAY 27, 2022

The development of guidance to support companies who require risk assessments when working with clinical trial data on selected computerised systems is welcomed. There is a huge opportunity for pharma companies to capitalise on by focusing on increased DEI in clinical trials. What comes next?

Clinical Trials 79

Clinical Trials Clinical Trials Trials Packaging 79

Drug Discovery World

OCTOBER 4, 2022

Taking place at the ExCel in London from 4-5 October, ELRIG Drug Discovery 2022 is set to provide visitors with access to the latest trends, technologies and expertise driving the life sciences sector. . million by Horizon Europe which will go towards its goal of developing bioprocessing technologies. . Automation.

Gene Therapy 52

Gene Therapy Drugs Gene Manufacturing 52

pharmaphorum

DECEMBER 2, 2020

The company’s first product, a palatable anti-parasitic drug, made to taste like toffee, united Pfizer’s skills as a chemist with Erhart’s training as a confectioner. It was a success, and set the pattern for the company’s future development. Pfizer’s Tokyo building.

Sales 128

Sales Production Drugs Marketing 128

XTalks

MAY 25, 2021

Humira is a TNF alpha inhibitor used to treat inflammatory conditions such as Crohn’s disease and was initially developed for the treatment of rheumatoid arthritis. According to a report by equitable drug development advocacy group I-MAK, Humira has the most patents out of the top-selling drugs in the country.

Production 98

Production Drugs Marketing Sales 98

pharmaphorum

DECEMBER 23, 2020

It has been a year dominated by the pandemic and many life sciences research projects were put on hold as big pharma turned its attention to vaccines and therapies. The company’s menopause drug NT-814 is heading for phase 3 development in 2021 following a mid-stage trial readout. Rare disease progress.

Marketing 77

Marketing Gene Silencing Gene Drugs 77

XTalks

AUGUST 24, 2021

In November 2020 during the third quarter, Berkshire spent billions of dollars on shares of four US pharma giants: AbbVie, Bristol Myers Squibb, Merck & Co. This was likely fueled by the flurry of development happening in the pharma space with COVID-19 vaccines and therapeutics. and Pfizer.

Drugs 98

Drugs Pharma Companies Vaccination Vaccine 98